Synthetic method for somatostatin

A technology of somatostatin and synthesis method, which is applied in the field of liquid phase synthesis of somatostatin, can solve the problems of steric hindrance, reduction of product optical rotation, hindering amino acid synthesis and the like

Active Publication Date: 2009-11-04
LANZHOU UNIVERSITY +1
View PDF8 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although it has the advantages of fast peptide incorporation, high yield, and short cycle, there are still problems: with the growth of the synthesized peptide chain, steric factors such as steric hindrance will appear, hind

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method for somatostatin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0050] Step 1, Fragment I: Synthesis of TFA Thr(Bzl)-Phe-Thr(Bzl)-Ser(Bzl)-Cys(MeOBzl)-OBzl

[0051] Weigh 4.1g (13.9mmol) of Boc-Ser(Bzl)-OH and dissolve it in 50ml of tetrahydrofuran, add 1.53ml (13.9mmol) of N-methylmorpholine, slowly add 1.8 ml (13.9 mmol) of isobutyl chloroformate, after 2-4 minutes, add 20 ml of a tetrahydrofuran solution of 4.6 g (13.9 mmol) of Cys(MeOBzl)-OBzl pre-cooled to below 0°C in the refrigerator. After the reaction was maintained at the low temperature for 30 minutes, the ice-salt bath was removed, and the reaction was resumed at room temperature for 4-6 hours, and the reaction was detected by TLC. Filter to remove salt, concentrate the filtrate, dissolve the residue in ethyl acetate, wash with 5% NaOH, water, 5% HCl, water, and saturated brine successively, dry with anhydrous NaSO4, concentrate and remove the solvent under reduced pressure to obtain a white solid Boc-Ser(Bzl)-Cys(MeOBzl)-OBzl 8.04g, yield 95%.

[0052] Pour 8.04 g of the obt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a liquid phase synthetic method for somatostatin, which is as follows: firstly, four segment peptides of Thr(Bzl)-Phe-Thr(Bzl)-Ser(Bzl)-Cys(MeOBzl)-Bzl, Boc- Phe-Trp-Lys(z)-OH, Boc-Asn-Phe-OH and Boc-Ala-Gly-Cys(MeOBzl)-Lys(z)-OH are respectively and total synthesized; and then EDCI/HOBt is used for fragment condensation to synthesize total protective reducibility tetradecapeptide; protecting groups possessed by trifluoromethanesulfonic acid and methyl-phenoxide system de-peptide chain are used for obtaining reducibility somatostatin which is oxidized to obtain somatostatin crude product; the somatostatin crude product is separated and purified by a C18 preparative column, is frozen and dried to obtain the somatostatin.

Description

technical field [0001] The invention relates to a liquid phase synthesis method of somatostatin. Background technique [0002] Chinese name: somatostatin. Other names: growth hormone releasing inhibitory hormone. Trade name: Shitanin. English name: Somatostatin, Stilamin. [0003] The structural formula is: [0004] Molecular formula: C 76 h 104 N 18 o 19 S 2 ;Molecular weight: 1637.8. [0005] Somatostatin is synthesized by the cells of the median eminence of the hypothalamus and the islets of the pancreas. In 1973, it was first isolated from the hypothalamus by Burgus and Brazean et al. and its structure was elucidated. The chemical structure is fourteen peptides with a pair of disulfide bonds in the molecule. Synthetic somatostatin has become a commodity for clinical use, and was included in the European Pharmacopoeia in 1997. [0006] The pharmacological effects of somatostatin are as follows: ① It can inhibit the secretion of growth hormone, thyroid stimu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K7/08C07K1/06C07K1/02A61P5/02A61P5/08A61P5/48A61P1/04A61P1/18A61P7/04
CPCY02P20/55
Inventor 达朝山苏亚宁洪满贵保英明曹福军
Owner LANZHOU UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap